CCL2 and metabolic dysfunction-associated steatohepatitis: During NASH development, CC-chemokine ligand (CCL)2 and its receptor, CC-chemokine receptor (CCR2), were upregulated in the liver and contributed to macrophage accumulation and inflammation [25].